Main Sector of relevance\IRC classification 10. Other Industrial Manufacturing Technologies


10.13 ZAMICIT - pharmaceutical substance and medical drug for AIDS treatment

ZAMICIT

Developers’ contact information

State Scientific Institution “The Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus”
5, bldg. 2, Kuprevich Str., 220141 Minsk

E.N. Kalinichenko
tel./fax.: +375 (17) 267-87-61; e-mail: babitskaya@iboch.bas-net.by

Summary

ZAMICIT is one of the most effective medical drugs used for human immunodeficiency virus (HIV) treatment.

Description

The original technology of chemosynthesis of the substance is protected by patent for invention of the Republic of Belarus No. 4156

Technology type

Technical advantages and economic benefits

ZAMICIT (Deoxycytidine, Hivid) is one of the most effective medical drugs used for human immunodeficiency virus (HIV) treatment. The original and extremely effective technology of producing the substance and drug products of ZAMICIT makes it possible to manufacture tablets containing 0.00035 g and 0.00075 g of active substance. The drug is not produced on the territory of CIS countries. The developed technology allows reducing the drug price 2-3-fold in comparison with foreign analogues.

Technology differentiation and uniqueness

The original high-technology synthesis scheme.

Context in which technology was identified

International Specialized Exhibition “Chemistry. Oil and Gas” 2006, 2008; National exhibition of the Republic of Belarus in the Bolivarian Republic of Venezuela “Expo Feria “BELARUS-2007”

Technological keywords

Antiviral, AIDS.

Development Stage

Intellectual property rights

Range of applications

Classifier Used at the EU Innovation Relay Centres

Preferable Regions

Practical experience

Introduction of the technology in production

Environmental impact

None

Type of collaboration sought

Terms and restrictions

Terms of the license contract

Available technical assistance